Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Journey Medical Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Journey Medical Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Toledano Miranda Jayne | Director | 168,618 | Jul 2, 2026 | 2 |
| Smith Justin Adam | Director | 231,618 | Jul 2, 2026 | 2 |
| Herskowitz Neil | Director | 168,618 | Jul 2, 2026 | 2 |
| Rosenwald Lindsay A MD | Director | 221,146 | Jun 26, 2026 | 1 |
| Pearce Michael Cooper | Director | 67,173 | Jun 26, 2026 | 1 |
| Benesch Joseph | CFO | 261,371 | Apr 24, 2026 | 1 |
| Maraoui Claude | President & CEO | 2,435,990 | Apr 24, 2026 | 1 |
| Alloush Ramsey | Chief Operating Officer | 598,543 | Apr 24, 2026 | 1 |
| Fortress Biotech, Inc. | 10% Owner | 3,860,467 | May 31, 2024 | 0 |
| Paley Jeffrey | Director | 114,217 | Dec 8, 2023 | 0 |
| De Paolantonio Ernest Robert | See Remarks | 259,907 | Mar 1, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | May 2 | 3 days | Maraoui ClaudePresident & CEO | SSaleCommon Stock, $0.0001 par value | −4.83K | $6.84 | −$33.1K | −0.2%2.35M after | |
| May 5, 2025 (view filing) | May 2 | 3 days | Benesch JosephCFO | SSaleCommon Stock, $0.0001 par value | −2.41K | $6.84 | −$16.5K | −1.2%203.6K after | |
| May 5, 2025 (view filing) | May 2 | 3 days | Alloush RamseyCOO | SSaleCommon Stock, $0.0001 par value | −2.86K | $6.84 | −$19.5K | −0.6%504.8K after | |
| Mar 11, 2025 (view filing) | Mar 11 | Same day | Maraoui ClaudePresident & CEO | SSaleCommon Stock, $0.0001 par value | −49.3K | $5.01 | −$246.8K | −2.4%2.00M after | |
| Mar 10, 2025 (view filing) | Mar 6-7 | 4 days | Maraoui ClaudePresident & CEO | SSaleCommon Stock, $0.0001 par value | −40.5K | $5.03 | −$203.5K | −1.9%2.05M after | 2 lots |
| Mar 5, 2025 (view filing) | Mar 3-5 | 2 days | Maraoui ClaudePresident & CEO | SSaleCommon Stock, $0.0001 par value | −70.6K | $5.11 | −$360.8K | −3.3%2.09M after | 3 lots |
| Feb 24, 2025 (view filing) | Feb 21 | 3 days | Benesch JosephCFO | SSaleCommon Stock, $0.0001 par value | −1.36K | $5.19 | −$7.08K | −2.9%46.0K after | |
| Aug 1, 2024 (view filing) | Aug 1 | Same day | Benesch JosephCFO | SSaleCommon Stock, $0.0001 par value | −9.32K | $5.47 | −$51.0K | −16.5%47.3K after | |
| Jul 23, 2024 (view filing) | Jul 23 | Same day | Benesch JosephCFO | SSaleCommon Stock, $0.0001 par value | −4.05K | $5.40 | −$21.9K | −6.7%56.7K after | |
| Mar 27, 2024 (view filing) | Mar 25 | 2 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, $0.0001 par value | +10.0K | $3.04 | +$30.4K | +7.4%144.2K after | |
| Mar 25, 2024 (view filing) | Mar 22 | 3 days | Maraoui ClaudePresident & CEO | PPurchaseCommon Stock, $0.0001 par value | +10.0K | $3.48 | +$34.8K | +0.5%2.16M after | |
| Mar 25, 2024 (view filing) | Mar 22 | 3 days | Smith Justin AdamDirector | PPurchaseCommon Stock, $0.0001 par value | +30.0K | $3.47 | +$104.1K | +28.6%134.7K after | |
| Mar 25, 2024 (view filing) | Mar 22 | 3 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, $0.0001 par value | +20.0K | $3.40 | +$68.0K | +17.5%134.2K after | |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Benesch JosephInterim CFO | SSaleCommon Stock, $0.0001 par value | −2.45K | $3.75 | −$9.19K | −3.9%60.7K after | |
| Dec 8, 2023 (view filing) | Nov 7-8 | 31 daysLate | Paley JeffreyDirector | SSaleCommon Stock, par value $0.0001 per share | −2.50K | $3.51 | −$8.77K | −2.1%114.2K after | 2 lots |
| Nov 29, 2023 (view filing) | Nov 28 | 1 day | Paley JeffreyDirector | SSaleCommon Stock, par value $0.0001 per share | −1.75K | $5.22 | −$9.11K | −2.4%70.7K after | |
| Oct 17, 2023 (view filing) | Oct 13 | 4 days | Smith Justin AdamDirector | PPurchaseCommon Stock, par value $0.0001 per share | +33.0K | $2.98 | +$98.3K | +46.0%104.7K after | |
| Oct 10, 2023 (view filing) | Oct 6 | 4 days | Paley JeffreyDirector | PPurchaseCommon Stock, par value $0.0001 per share | +15.0K | $2.98 | +$44.7K | +26.1%72.5K after | |
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Paley JeffreyDirector | PPurchaseCommon Stock, par value $0.0001 per share | +30.0K | $2.97 | +$89.1K | +109.2%57.5K after | |
| Sep 8, 2023 (view filing) | Sep 6 | 2 days | Maraoui ClaudePresident & CEO | PPurchaseCommon Stock, par value $0.0001 per share | +26.0K | $2.52 | +$65.6K | +1.2%2.15M after | |
| Sep 8, 2023 (view filing) | Sep 6 | 2 days | Rosenwald Lindsay A MDDirector | PPurchaseCommon Stock, par value $0.0001 per share | +100.0K | $2.23 | +$223.0K | +702.0%114.2K after | |
| Jul 25, 2023 (view filing) | Jul 24 | 1 day | Maraoui ClaudePresident & CEO | SSaleCommon Stock, par value $0.0001 per share | −20.8K | $1.76 | −$36.5K | −1.0%2.13M after | |
| Jul 25, 2023 (view filing) | Jul 24 | 1 day | Benesch JosephSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −4.07K | $1.76 | −$7.17K | −6.1%63.2K after | |
| May 18, 2023 (view filing) | May 16-17 | 2 days | Maraoui ClaudePresident & CEO | SSaleCommon Stock, par value $0.0001 per share | −44.4K | $1.30 | −$57.7K | −2.0%2.15M after | 2 lots |
| Mar 1, 2023 (view filing) | Oct 4, 2022 | 148 days | De Paolantonio Ernest RobertSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −10.1K | $2.41 | −$24.3K | −3.7%259.9K after | Amended |
| Feb 23, 2023 (view filing) | Feb 22 | 1 day | Benesch JosephInterim CFO | SSaleCommon Stock, par value $0.0001 per share | −2.77K | $1.97 | −$5.45K | −4.0%67.2K after |